Clinical trial

Pravastatin to Prevent Preeclampsia

NCT03944512

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-07-17

PhasePHASE3

Study timeline

Study start (actual)2019-07-17Date precision: day

Registry last updated2025-12-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Preeclampsiaunresolved

Obstetric Labor Complicationsunresolved

Hypertension in Pregnancyunresolved

Interventions

PravastatinDRUG · verified · RxNorm: pravastatin

Sponsors & collaborators

The George Washington University Biostatistics Centerlead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

New YorkNew York, United States1 HoustonTexas, United States1 ChicagoIllinois, United States1 PhiladelphiaPennsylvania, United States1 ClevelandOhio, United States1 PittsburghPennsylvania, United States1 BirminghamAlabama, United States1 ColumbusOhio, United States1 Salt Lake CityUtah, United States1 Chapel HillNorth Carolina, United States1 ProvidenceRhode Island, United States1 GalvestonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03944512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.